Search
for
Sort by
Research 601–630 of 1000+
- Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Review of modern methods of treating vitiligo
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Tofacitinib in the Management of Alopecia Universalis
- Targeted immunotherapy for hair regrowth and regeneration
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Successful Treatment of Canities Subita with Baricitinib
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Deuruxolitinib for Alopecia Areata.
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- Alopecia areata: recognition, diagnosis and management
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Ritlecitinib: First Approval
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib